Current Report · Items 8.01, 9.01 · 8-K
TriSalus Life Sciences, Inc.
TLSINASDAQEQUITYCurrent
Other Events
Item 8.01 Other Events. On September 22, 2026, TriSalus Life Sciences, Inc. (the “Company”) issued a press release announcing that it has received U.S. Food and Drug Administration (“FDA”) 510(k) clearance for its TriNav Advance device. With FDA clearance, the Company expects to commence commercialization.…
Company context
Current securities
Disclosure sections
Item 8.01Item 8.01 - Other Events
Item 8.01 Other Events.
On September 22, 2026, TriSalus Life Sciences, Inc. (the “Company”) issued a press release announcing that it has received U.S. Food and Drug Administration (“FDA”) 510(k) clearance for its TriNav Advance device. With FDA clearance, the Company expects to commence commercialization. A copy of the press release is attached hereto as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.